title: Can beta agonists cause dilated cardiomyopathy?
abstract: We report a case of dilated cardiomyopathy that we believe is secondary to excessive use of inhaled beta agonists. Clinicians should be mindful of this possibility when using beta agonists to treat patients with obstructive airways disease; particularly if there is already recognised left ventricular dysfunction.
authors.affiliation: Department of Vascular Surgery, Auckland City Hospital, New Zealand. AnwarC@adhb.govt.nz
authors.forename: Anwar S
authors.initials: AS
authors.lastname: Choudhary
authors.forename: Geoffrey M
authors.initials: GM
authors.lastname: Robinson
mesh_terms: D000318:Adrenergic beta-Agonists / Q000008:administration & dosage / Q000009:adverse effects*; D000420:Albuterol / Q000008:administration & dosage / Q000009:adverse effects* / Q000031:analogs & derivatives*; D000730:Androstadienes / Q000008:administration & dosage / Q000009:adverse effects*; D001249:Asthma / Q000000981:diagnostic imaging / Q000188:drug therapy; D001993:Bronchodilator Agents / Q000008:administration & dosage / Q000009:adverse effects*; D002311:Cardiomyopathy, Dilated / Q000139:chemically induced* / Q000000981:diagnostic imaging; D000068298:Fluticasone; D006801:Humans; D008297:Male; D008875:Middle Aged; D011859:Radiography; D000068299:Salmeterol Xinafoate
chemical_list: D000318:Adrenergic beta-Agonists; D000730:Androstadienes; D001993:Bronchodilator Agents; D000068299:Salmeterol Xinafoate; D000068298:Fluticasone; D000420:Albuterol